openPR Logo
Press release

Latin America Biochips Market with business strategies and analysis to 2021.

07-10-2017 02:51 PM CET | Health & Medicine

Press release from: Market Data Forecast

Market Data Forecast

Market Data Forecast

The Latin America Biochips Market was worth $0.69 billion in 2016 and estimated to be growing at a CAGR of 18.34%, to reach $1.61 billion by 2021. A biochip is an assembly of miniaturized test sites that are organized on a compact substrate, which allows many tests to be executed at the same time to reach higher throughput and speed.

Usually, the surface area of a biochip is no bigger than a fingernail. Like a computer chip that can accomplish millions of mathematical tasks in one second, a biochip can implement thousands of biological responses, such as decoding genes, in the duration of a few seconds.

View full report at: http://www.marketdataforecast.com/market-reports/latin-america-biochips-market-1634/

The growth of the Latin America Biochips Market is mainly driven by factors such as an increased application in cancer study, surge in the utilization of personalized medicine, and increased commercial uses of biochips. However, factors such as an availability of substitute technologies, low commercial suitability due to higher costs, and standardization concerns are restraining the growth of the market in this region.

The Latin America Biochips market is segmented based on Type, End User, and Fabrication Technology. The market for Biochips, on the basis of Type is segmented into DNA Chips, Lab-On-A-Chip, and Protein Chips. DNA Chips are further segmented into SNP Genotyping, Genomics, Agricultural Biotechnology, Gene Expression, Cancer Diagnosis & Treatment, Drug Discovery, and Others. Lab-On-A-Chips are further segmented into Clinical Diagnostics, IVD & POC, Drug Discovery, Genomics, and Proteomics. Protein Chips are further segmented into Expression Profiling, High-Throughput Screening, Proteomics, Diagnostics, and Drug Discovery. On the basis of type, DNA Chips are the largest segment, followed by lab-on-chips and protein biochips market, due to development in the proteomics and genomics field. However, enhancement in the field of recombinant proteins would assist the growth of protein biochips market. On the basis of End User, the Biochips market is segmented into Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, Academic & Research Institutes. The Hospitals and Diagnostics Center segment dominates the market, as it is primarily driven by various factors such as increasing government funding and technological advancements.

Request sample: http://www.marketdataforecast.com/market-reports/latin-america-biochips-market-1634/request-sample

Latin America market region includes countries such as Brazil, Mexico, Argentina, and remaining countries of South America. Brazil is the largest market for Biochips, followed by Mexico, Colombia, and Argentina. With the exception of Brazil and Mexico, the medical regulatory environment in this region is inconsistent when compared to developed countries.

The recent developments in the global biochips market include the outsourcing of biochips technology, which would aid in decreasing labor cost and capital prerequisites. The major companies dominating the Biochips market in this region are Agilent Technologies Inc., Fluidigm Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., GE Healthcare, Cepheid Inc., Illumina Inc., and Thermo Fisher Scientific Inc.

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

Contact:

Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Latin America Biochips Market with business strategies and analysis to 2021. here

News-ID: 617326 • Views: 130

More Releases from Market Data Forecast

Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to incre …
Overview: Veterinary Vaccines Market has seen significant growth over the past few years, due to alarm of imminent epidemics that have led to substantial losses, particularly in poultry segment. View sample and decide: https://www.marketdataforecast.com/market-reports/veterinary-vaccines-market-75/customize-report Market views: Global Veterinary Vaccines market value is estimated to grow at a CAGR of 5.5% to increase to reach a market value to USD 8.46 Billion by 2023. Drivers and restraints: Veterinary Vaccine market has displayed a noteworthy growth in recent years which
Protein Labelling Market Global Growth, Trends, And Forecast To 2024
Recent developments: Proteins are the biggest and most essential biomolecules in a living life form, as they are imperative to the working of a creature. When they are shaped inside a cell, proteins associate with different biomolecules and do jobs to keep the cell alive. Merck's FITC labeling kit gives intends to rapidly and just mark antibodies or different proteins with fluorescein. Coordinate marking of the essential immune response disposes of the
Agricultural biotechnology market– Dupont opened its integrated science and bi …
Recent Developments Du Pont is a science and technology company. This company introduce agriculture products, containing the soybean seed and hybrid corn varients mainly under the brand named Pioneer, canola, sorghum, sunflower,  wheat, and rice seeds; silage inoculants, and insect,  weed, disease control products, DuPont introduced its first integrated science and biotechnology center, the DuPont Knowledge Center (DKC) in Hyderabad, Telangana state, in 2008. It is a 20-acre campus with a recent
The endovenous ablation segment is expected to command the major share of the Eu …
Overview The Europe Varicose Vein Treatment Market was worth USD 95.4 million in 2018 and estimated to be growing at a CAGR of 6.3%, to reach USD 129.49 million by 2023. The varicose vein treatment market is mainly driven by the rising cases of varicose veins. This condition of enlarged veins appears mostly in feet and legs. It can be caused by pregnancy, hormonal changes, genetic disorders and high blood pressure. View a

All 2801 Releases


More Releases for Biochips

Biochips Market Structure Analysis by 2020
Bio-microsystem is a group of miniaturized and integrated devices for biological or biochemical reactions in diagnostics, monitoring, therapy, and research and development. Some of the advantages of bio-microsystems are parallelism, integrated intelligence, low cost, speed, complexity and redundancy. Biochip is one of the examples of technical development of bio-microsystem. Biochip is a collection of microarrays arranged on a solid substrate which allows hundreds or thousands of complex biochemical reactions such
Biochips Market Competitive landscape analysis 2023
Market Overview: The global Biochips market is valued at $10.61 billion in 2018 and envisioned to be developing at a CAGR of 21.80%, to attain $28.44 billion by 2023. A biochip is a set of microarrays organized on a strong substrate which allows hundreds or masses of complicated biochemical reactions which include deciphering genes in a few seconds. Biochips are utilized in a fashion of packages such as studies utility in
Global Biochips Market: mainly propelled by rising applications of biochips
SAN FRANCISCO, May. 02, 2018 According to the latest report published by Variant Market Research, the global biochips market size is projected to reach $22 billion by 2024 from $6 billion in 2016. In this report, global biochips market forecast says that the global market is growing at 15.5% CAGR from 2016 to 2024. On the basis of geography, Asia Pacific is expected to grow at a CAGR of 16.7%
Biochips Market Greater Revenue Share by 2020
Bio-microsystem is a group of miniaturized and integrated devices for biological or biochemical reactions in diagnostics, monitoring, therapy, and research and development. Some of the advantages of bio-microsystems are parallelism, integrated intelligence, low cost, speed, complexity and redundancy. Biochip is one of the examples of technical development of bio-microsystem. Biochip is a collection of microarrays arranged on a solid substrate which allows hundreds or thousands of complex biochemical reactions such
Biochips Market - Global Industry Analysis 2025
Biochips are known as miniature laboratories or fundamental functional units that are capable of performing various biochemical reactions simultaneously. The size of a biochip is that of a fingernail. The biochip performs a large number of biological reactions in a few seconds such as analyzing contamination and gene decoding. The functional unit is a collection of miniaturized microarrays or test sites arranged on a solid substrate, which performs multiple tests,
Discover the Growth of the Biochips Market
Bio-microsystem is a group of miniaturized and integrated devices for biological or biochemical reactions in diagnostics, monitoring, therapy, and research and development. Some of the advantages of bio-microsystems are parallelism, integrated intelligence, low cost, speed, complexity and redundancy. Biochip is one of the examples of technical development of bio-microsystem. Biochip is a collection of microarrays arranged on a solid substrate which allows hundreds or thousands of complex biochemical reactions such